Teva UK Ltd & Ors v Gilead Sciences, Inc [2019] EWCA Civ 2272

19 December 2019

“On 19 December 2019, the Court of Appeal issued its judgment in Teva v. Gilead concerning the supplementary protection certificate relating to the antiviral combination sold under the name Truvada ®.  Gilead’s appeal from Arnold J was dismissed and the court confirmed the invalidity of the SPC on the ground of non-compliance with Article 3(a) of the Regulation.   Daniel Alexander QC and James Whyte at 8 New Square acted in the case which, at an earlier stage, involved one of the relatively rare full Grand Chamber hearings before the CJEU”.

View judgment